TRS003

· Zhejiang Teruisi Pharmaceutical Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TRS003, covering 2020-06-16 to 2022-05-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC [Phase 3]